Abstract
The discovery by Trentin et al. (1962) that human adenoviruses were capable of producing tumors when inoculated into hamsters created a major role for these agents in the field of viral oncology. As participants in this field, several of the adenovirus (Ad) serotypes are among the most thoroughly studied animal viruses. One of the primary objectives of the study of these agents as tumor viruses has been to elucidate the mechanisms that are associated with their capacity to convert normal cells to neoplastic cells that produce tumors in animals. In approaching this objective, theoretical and technical developments have focused current research on the structure, organization, and expression of the Ad genome, and much has been accomplished. The functional arrangement of the Ad2 genome has been determined and the DNA sequence structure of several Ad serotypes is far advanced. The processing of Ad RNA into cytoplasmic mRNA that is translated into viral proteins has provided new insights into the mechanisms of RNA transcription in eukaryotic organisms. The mode of replication of the Ad genomes is under intensive investigation. The regions of the viral genome that are associated with the conversion of normal cells to neoplastic cells have been located, and many of the proteins encoded by these genes have been identified and in some cases purified. For detailed discussions of these developments, we refer the reader to other chapters in this volume and to recent reviews by Flint (1980a, b), Persson and Philipson (1982), Challberg and Kelly (1982), and Doerfler (1982). In spite of these impressive accomplishments, the goal of defining the mechanism of Ad-induced carcinogenesis has remained elusive, and it is becoming increasingly apparent that the question of how viruses and neoplastic cells produce tumors in animals will most likely remain after understanding of the molecular mechanisms of cell transformation (as defined by the induction of immortality) in vitro has been reached. The complexities of the interactions between cells rendered neoplastic by adenoviruses and the cellular immune defenses of the potential animal host suggest that new concepts and approaches to the possible mechanism of viral carcinogenesis are needed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Akagi T, Ogawa K (1972) Relationship among tumorigenicity, T antigen, and virus-specific transplantation antigen in adenovirus type 12 transformed and tumor cells. Gan 63: 307–312
Allison AC, Berman LD, Levey RH (1967) Increased tumor induction by adenovirus type 12 in thymectomized mice and mice treated with anti-lymphocyte serum. Nature 215: 185–187
Ankerst J, Sjögren HO (1969) Cross-reacting TSTAs in adeno 7 and 12 tumors demonstrated by 51Cr-cytotoxicity and isograft rejection tests. Int J Cancer 4: 279–287
Ankerst J, Sjögren HO (1970) Cross-reacting tumor-specific transplantation of antigens in tumors induced by adenoviruses 3, 14, and 12. Cancer Res 30: 1499–1505
Berman LD (1967) On the nature of transplantation immunity in the adenovirus tumor system. J Exp Med 125: 983–999
Billingham RE, Sawchuck GH, Silvers WK (1960) The induction of tolerance of skin homografts in Syrian hamsters. Transplant Bull 26: 446–449
Challberg MD, Kelly TJ Jr (1982) Eukaryotic DNA replication: viral and plasmid model systems. Ann Rev Biochem 51: 901–934
Collins JL, Patek PQ, Cohn M (1981) Tumorigenicity and lysis by natural killers. J Exp Med 153: 89–106
Cook JL, Lewis AM Jr (1979) Host response to adenovirus 2-transformed hamster embryo cells. Cancer Res 39: 1455–1461
Cook JL, Kirkpatrick CH, Rabson AS, Lewis AM Jr (1979a) Rejection of adenovirus 2-transformed cell tumors and immune responsiveness in Syrian hamsters. Cancer Res 39: 4949–4955
Cook JL, Lewis AM Jr, Kirkpatrick CH (1979b) Age-related and thymus-dependent rejection of adenovirus 2-transformed cell tumors in the Syrian hamster. Cancer Res 39: 3335–3340
Cook JL, Hibbs JB Jr, Lewis AM Jr (1980) Resistance of simian virus 40-transformed hamster cells to the cytolytic effect of activated macrophages: a possible factor in species-specific viral oncogenicity. Proc Natl Acad Sci USA 77: 6773–6777
Cook JL, Hibbs JB Jr, Lewis AM Jr (1982) DNA virus-transformed hamster cell-host effector cell interactions: level of resistance to cytolysis correlated with tumorigenicity. Int J Cancer 30: 795–803
Cook JL, Hauser J, Patch C, Lewis AM Jr, Levine AS (1983) Adenovirus 2 early gene expression promotes susceptibility to effector cell lysis of hybrids formed between adenovirus 2 and simian virus 40 transformed hamster cells. Proc Natl Acad Sci USA 80: 5995–5999
Doerfler W (1982) Uptake, fixation, and expression of foreign DNA in mammalian cells: the organization of integrated adenovirus DNA sequencer. In: Graf T, Jaenisch R (eds) Tumor viruses, Neoplastic Transformations, and Differentiation. Springer, Berlin Heidelberg New York, pp 127–194 (Current topics in microbiology and immunology, vol 101 )
Eddy BE, Grubbs GE, Young RD (1964) Tumor immunity in hamsters infected with adenovirus 12 or simian virus 40. Proc Soc Exp Biol Med 117: 575–579
Flint SJ (1980a) Structure and organization of adenoviruses. In: Tooze J (ed) Molecular biology of tumor viruses. Part 2, DNA tumor viruses. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, pp 383–442
Flint SJ (1980b) Transformation by adenoviruses. In: Tooze J (ed) Molecular biology of tumor viruses. Part 2, DNA tumor viruses. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, pp 547–576
Foulds L (1969) Neoplastic development. Academic, London
Gallimore PH (1972) Tumour production in immunosuppressed rats with cells transformed in vitro by adenovirus type 2. J Gen Virol 16: 99–102
Gallimore PH, Paraskeva C (1980) A study to determine the reasons for differences in the tumorigenicity of rat cell lines transformed by adenovirus 2 and adenovirus 12. Cold Spring Harbor Symp Quant Biol 44: 703–713
Gallimore PH, McDougall JK, Chen LB (1977) In vitro traits of adenovirus-transformed cell lines and their relevance to tumorigenicity in nude mice. Cell 10: 669–678
Gilden RV, Kern J, Freeman AE, Martin CE, McAllister RM, Turner HC, Huebner RJ (1968) T and tumor antigens of adenovirus group C-infected and transformed cells. Nature 219: 517–518
Girardi AJ, Hilleman MR, Zwickey RE (1964) Tests in hamsters for oncogenic quality of ordinary viruses including adenovirus type 7. Proc Soc Exp Biol Med 115: 1141–1150
Green M, Mackey JK, Wold WSM, Rigden P (1979) Thirty-one human adenovirus serotypes (Ad1-Ad31) from five groups ( A-E) based upon DNA genome homologies. Virology 93: 481–492
Haller O, Orn A, Gidlund M, Wigzell H (1980) In vivo activity of murine NK cells. In: Herberman RB (ed) Natural cell-mediated immunity against tumors. Academic, New York, pp 1105–1116
Harwood LMJ, Gallimore PH (1975) A study of the oncogenicity of adenovirus type 2 transformed rat embryo cells. Int J Cancer 16: 498–508
Henney CS (1981) Do natural killer cells function through recognition of glycoconjugates on target cell membranes? In: Saunders JP, Daniels JC, Serrou B, Rosenfeld C, Denney CB (eds) Fundamental mechanisms in human cancer immunology. Elsevier/North Holland, New York, pp 465–475
Herberman R (1981) Overview of role of macrophages, natural killer cells, and antibody dependent cellular cytotoxicity as mediators of biological response modification. In: Chirigos MA, Mitchel M, Mastrangelo MJ, Krim M (eds) Mediation of cellular immunity in cancer by immune modifiers. Raven, New York, pp 261–267
Herberman RB, Ortaldo JR (1981) Natural killer cells: their role in defenses against disease. Science 214: 24–30
Huebner RJ (1967) Adenovirus-directed tumor and T antigens. In: Pollard M (ed) Perspectives in virology, vol 5. Academic, New York, pp 147–166
Huebner RJ, Rowe WP, Lane WT (1962) Oncogenic effects in hamsters of human adenovirus types 12 and 18. Proc Natl Acad Sci USA 48: 2051–2058
Huebner RJ, Lane WT, Welch AD, Calabresi P, McCollum RW, Prusoff WH (1963a) Inhibition by 5-iododeoxyuridine of the oncogenic effects of adenovirus type 12 in hamsters. Science 142: 488–490
Huebner RJ, Rowe WP, Turner HC, Lane WT (1963 b) Specific adenovirus complement-fixing antigens in virus-free hamster and rat tumors. Proc Natl Acad Sci USA 50:379–389 Adenovirus-Transformed Cells and Cellular Immune Response 21
Kiessling R, Wigzell H (1979) An analysis of the murine NK cell as to structure, function, and biological relevance. Immunol Rev 44: 165–208
Kirschstein RL, Rabson AS, Peters EA (1964) Oncogenic activity of adenovirus 12 in thymectomized BALB/c and C3H/HeN mice. Proc Soc Exp Biol Med 117: 198–200
Kvist D, Östberg L, Persson H, Philipson L, Peterson PA (1978) Molecular association between transplantation antigens and cell surface antigen in adenovirus-transformed cell line. Proc Natl Acad Sci USA 75: 5674–5678
Lewis AM Jr, Cook JL (1979) Association of tumor induction by ultraviolet light-inactivated adenovirus 2-simian virus 40 recombinants with a specific segment of simian virus 40 DNA. J Natl Cancer Inst 63: 695–705
Lewis AM Jr, Cook JL (1980) Presence of allograft-rejection resistance in simian virus 40-transformed hamster cells and its possible role in tumor development. Proc Natl Acad Sci USA 77: 2886–2889
Lewis AM Jr, Cook JL (1982) Spectrum of tumorigenic phenotypes among adenovirus 2, adenovirus 12, and simian virus 40-transformed Syrian hamster cells defined by host cellular immune-tumor cell interactions. Cancer Res 42: 939–944
McAllister RM, MacPherson I (1968) Transformation of a hamster cell line by adenovirus 12. J Gen Virol 2: 99–106
McAllister RM, Nicolson MO, Reed G, Kern J, Gilden RV, Huebner RJ (1969) Transformation of rodent cells by adenovirus 19 and other group D adenoviruses. J Natl Cancer Inst 43: 917–922
Patch C, Hauser J, Lewis AM Jr, Levine AS (1983) Adenovirus 2 early gene expression reduces the tumor-inducing capacity of hybrid cells formed from simian virus 40- and adenovirus 2-transformed hamster embryo cells. Cancer Res 43: 2571–2575
Persson H, Philipson L (1982) Regulation of adenovirus gene expression. In: Cooper M et al. (eds) Current topies in microbiology and immunology, vol 97. Springer, Berlin Heidelberg New York, pp 157–203
Persson H, Kvist S, Ostberg L, Peterson PA, Philipson L (1980) Adenoviral early glycoprotein E3–19K and its association with transplantation antigens. Cold Spring Harbor Symp Quant Biol 45: 509–517
Persson H, Katze MG, Philipson L (1982) Purification of a native membrane-associated adenovirus tumor antigen. J Virol 42: 905–917
Rabson AS, Kirschstein RL, Paul FJ (1964) Tumors produced by adenovirus 12 in mastomys and mice. J Natl Cancer Inst 32: 77–87
Rask L, Lindblom JB, Peterson PA (1974) Subunit structure of H-2 alloantigens. Nature 249: 833–835
Raska K Jr, Gallimore PH (1982) An inverse relation of the oncogenic potential of adenovirus transformed cells and their sensitivity to killing by syngeneic natural killer cells. Virology 123: 8–18
Raska K Jr, Morrongiello MP, Fohring B (1980) Adenovirus type 12 tumor antigen. III. Tumorigenicity and immune response to syngeneic rat cells transformed with virions and isolated transforming fragment of adenovirus 12 DNA. Int 7 Cancer 26: 79–86
Raska K Jr, Dougherty J, Gallimore PH (1982) Product of adenovirus type 2 early gene block E1 in transformed cells elicits cytolytic response in syngeneic rats. Virology 117: 530–535
Sehgal PB, Frazer NW, Darnell JE (1979) Early Ad2-transcription units: only promoter-proximal RNA continues to be made in the presence of DRB. Virology 94: 185–191
Shiroki K, Shimojo H, Maeta Y, Hamada C (1979) Tumor-specific transplantation and surface antigen in cells transformed by the adenovirus 12 DNA fragments. Virology 99: 188–191
Signas C, Katze MG, Persson H, Philipson L (1982) An adenovirus glycoprotein binds heavy chains of class I transplantation antigens from man and mouse. Nature 299: 175–177
Silver J, Hood L (1974) Detergent-solubilized H-2 alloantigen is associated with a small molecular weight polypeptide. Nature 249: 764–765
Sjögren HO, Ankerst J (1969) Effect of BCG and allogeneic tumor cells on adenovirus type 12 tumorigenesis in mice. Nature 221: 863–864
Sjögren HO, Minowada J, Ankerst J (1967) Specific transplantation antigens of mouse sarcomas induced by adenovirus type 12. J Exp Med 125: 689–701
Tevethia SS (1980) Immunology of simian virus 40. In: Klein G (ed) Viral oncology. Raven, New York, pp 581–602
Trentin JJ, Bryan E (1966) Virus-induced transplantation immunity to human adenovirus type 12 tumors of the hamster and mouse. Proc Soc Exp Biol Med 121: 1216–1219
Trentin JJ, Yabe Y, Taylor G (1962) The quest for human cancer viruses. Science 137: 835–841
Trentin JJ, Van Hoosier GL Jr, Samper L (1968) The oncogenicity of human adenoviruses in hamsters. Proc Soc Exp Biol Med 127: 683–689
Vitetta ES, Uhr JW, Boyse EA (1975) Association of a /32-microglobulin-like subunit with H-2 and TL alloantigens J Immunol 114: 252–254
Wadell G (1979) Classification of human adenoviruses by SDS-polyacrylamide gel electrophoresis of structural polypeptides. Intervirology 11: 47–57
Wadell G, Hammarskjöld ML, Winberg G, Varsanyi TM, Sundell G (1980) Genetic variability of adenoviruses. Ann NY Acad Sci USA 354: 16–42
Wilson MC, Fraeser NW, Darnell JE (1979) Mapping of RNA initiation sites by high doses of UV irradiation: evidence for three independent promoters within the left 11% of the Ad2 genome. Virology 94: 175–184
Yabe Y, Trentin JJ, Grant T (1962) Cancer induction in hamsters by human type 12 adenovirus. Effect of age and of virus dose. Proc Soc Exp Biol Med 111: 343–344
Yabe Y, Samper L, Grant T, Trentin JJ (1963) Cancer induction in hamsters by human type 12 adenovirus. Effect of route of injection. Proc Soc Exp Biol Med 113: 221–224
Yabe Y, Samper L, Bryan E, Taylor G, Trentin J (1964) Oncogenic effect of human adenovirus type 12 in mice. Science 143: 46–47
Yohn DS, Funk CA, Kalnins VI, Grace JT Jr (1965) Sex-related resistance in hamsters to adenovirus-12 oncogenesis. Influence of thymectomy at three weeks of age. J Natl Cancer Inst 35: 617–624
Yohn DS, Funk CA, Grace JT (1968) Sex-related resistance in hamsters to adenovirus 12 oncogenesis. III. Influence of immunologic impairment by thymectomy or cortisone. J Immunol 100: 771–780
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Lewis, A.M., Cook, J.L. (1984). The Interface Between Adenovirus-Transformed Cells and Cellular Immune Response in the Challenged Host. In: Doerfler, W. (eds) The Molecular Biology of Adenoviruses 2. Current Topics in Microbiology and Immunology, vol 110. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-46494-2_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-46494-2_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-46496-6
Online ISBN: 978-3-642-46494-2
eBook Packages: Springer Book Archive